IVF Life Group and Reproductive Health Group join forces to further expand the IVF Life Group footprint and capabilities across Europe
Reproductive Health Group (RHG), one of the most advanced human fertility clinics in the UK, founded by Professor Luciano Nardo, joins the IVF Life Group to improve outcomes, patient experience and further innovation within the field.
IVF Life Group has announced today its merger with RHG, a young and leading reproductive medicine clinic based in the North of England. This operation is a transformative one within the assisted reproduction sector, IVF Life Group further strengthens its pan-European footprint, while integrating a world-class medical and scientific team led by the renowned reproductive medicine specialist and surgeon Professor Luciano Nardo. The IVF Life and RHG integration will enhance their scientific and technological innovation programmes. The common culture and cross-collaboration between the clinics and laboratories will boost the Group’s focus on offering truly personalised care and innovative application of reproductive medicine for the most challenging and complex cases.
The IVF Life Group was originally founded in 2009 and is still entirely led by healthcare professionals, including now Spanish, German and Swiss companies. The Group has clinics in Spain (IVF Spain Alicante, IVF Spain Madrid and IVF Donostia in San Sebastian), Germany (IVF Baden-Baden) and now in the United Kingdom, as well as other biotech companies in the area of reproductive genetics and regenerative medicine. IVF Life Group is relentlessly working towards bringing its patient-centred, personalised and successful reproductive medicine model closer to patients across Europe.
Professor Nardo commented on the merger: “The ultimate goal of this union is to share best practices and latest technology at every level, and always for the benefit of our patients and staff. We share a vision of enhancing success via tailored investigations and care.”
IVF-Life Group’s CEO, Almudena Moreno, has emphasised that “the integration of RHG within our growing IVF Life Group represents an important milestone for us, with the aim of making innovative medicine available to all patients, regardless of their origin. This step forward comes from a common vision and a common objective of offering the most personalised reproductive medicine across Europe.”
The common culture and cross-collaboration between RHG and the clinics at IVF Life Group and laboratories will boost the Group’s focus on offering truly personalised care and innovative application of reproductive medicine for the most challenging and complex cases.
